GLPwatch
Postprandiale Hyperglykämien: Rascheres Insulin aspart, einmal wöchentliches Semaglutid.
Med Monatsschr Pharm · 2016
Last updated 2026-05-28| Journal | Med Monatsschr Pharm, 2016 |
|---|---|
| Citations | 0 |
| Relative citation ratio | 0.00 |
| NIH percentile | 0 |
| Molecules | — |
| Conditions studied | Type 2 Diabetes |
Full record and abstract on PubMed 29956530 ↗